NUAN Stock Is a New IT Innovators Buy

Nuance is turning a corner, and wise investors will want a chance to get in

    View All  
NUAN Stock Is a New IT Innovators Buy

At first glance, Nuance Communications (NUAN) has a few factors working against it. The company is in the midst of a long-term transition to a new business model, has posted a string of earnings disappointments, and saw shares flounder last year as the overall market soared.

Nuance 150x150 NUAN Stock Is a New IT Innovators BuyBut dig deeper and you’ll see that this speech recognition software company stands out as a game changer thanks to its impressive technology, large-cap ally, and a big-name activist shareholder with a large stake in its future. And with evidence the company’s results are turning a corner, the stock is an attractive buy at current prices ahead of strong potential growth.

Even if you’re not familiar with Nuance, you’re likely on friendly terms with one of its most famous software personas. NUAN powers Siri, the ubiquitous personal assistant that so many iPhone users look to for directions, where to eat or just some disembodied conversation. NUAN earns revenue from Apple (AAPL) via flat fees, which are not determined by how many phones it sells. So the tech juggernaut’s recent low iPhone sales number, while disappointing, does not necessarily mean any problems for NUAN. And while NUAN is a bit of an indirect play on AAPL, no customer accounts for 10% or more of sales, which adds further downside protection.

The company also makes Dragon NaturallySpeaking software, which converts speech into text for PCs, and recently announced that it will work with Intel to introduce new voice recognition into Atom and core chips powering notebooks. Another key product is Nuance’s Swype technology, which has been making inroads into Android-powered devices.

All told, Nuance operates in several segments, including healthcare (49% of revenues), mobile and consumer (25% of revenues), enterprise (17%) and imaging. Given the size of the company’s revenue presence in healthcare, Nuance stands to benefit nicely from the continued push via government legislation for IT advancement in this sector, including better record keeping (transcribing doctor’s voice recordings) and more efficient treatment. In fact, management has said this segment should see double-digit growth going forward.

As I mentioned earlier, Nuance is in the midst of a long-term business model transition, moving to a software-as-a-service (SaaS) model to sell subscriptions to its products that are then delivered via the cloud. This is a departure from its traditional licensing (and installed on premise) model. While the transition has not been a smooth one, the new set up will ultimately help the company improve efficiency. This is similar to what we’ve seen from HomeAway (AWAY), which was pressured by investor concerns over its business model change but rose on evidence of a beneficial and smooth transition.

Looking at the revenue trajectory, growth rates have dropped from double digits to mid-single digits in the last year, and guidance and earnings reports disappointed over several quarters. As license sales drop and are only partly compensated by recurring revenue/maintenance sales, margins get hit. While overall revenue growth has been impressive on a non-GAAP basis (which includes the accounting impact of the revenue recognition timing changes tied to the shift), much of that growth has been driven by dozens of acquisitions over the past several years.


Article printed from InvestorPlace Media, http://investorplace.com/2014/02/stocks-to-buy-nuan-stock-aapl-away/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.